Immunovant (IMVT) Gets a Buy From Piper Sandler

TipRanksApr 26 19:52

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

Yahoo FinanceApr 22 23:53

Don't Ignore The Insider Selling In Immunovant

We wouldn't blame Immunovant, Inc. (NASDAQ:IMVT) shareholders if they were a little worried about the fact that Peter Salzmann, the CEO & Director recently netted about US$990k selling shares at an av

Simply Wall StApr 22 18:00

Buy Rating Affirmed for Immunovant on Strong Drug Development Prospects and Efficacy Confidence

TipRanksApr 22 17:55

Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing

Peter Salzmann, Director, Chief Executive Officer, on April 17, 2024, sold 34,079 shares in Immunovant (IMVT) for $990,269. Following the Form 4 filing with the SEC, Salzmann has control over a total

MT NewswiresApr 20 06:01

What Makes Immunovant (IMVT) a New Buy Stock

Yahoo FinanceApr 18 00:00